First Quadrant’s Thermo Fisher Scientific TMO Stock Holding History

First Quadrant’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17	Closed	-$10K	–	548
2021 Q3	$10K	Buy	+17	New	+$9.33K	﹤0.01%	510
2019 Q3	–	Sell	-40,404	Closed	-$11.9M	–	669
2019 Q2	$11.9M	Sell	40,404 -8,487	-17%	-$2.34M	0.82%	18
2019 Q1	$13.4M	Sell	48,891 -11,686	-19%	-$2.91M	1.03%	15
2018 Q4	$13.6M	Hold	60,577	–	–	1.09%	14
2018 Q3	$14.8M	Sell	60,577 -200	-0.3%	-$46K	0.33%	118
2018 Q2	$12.6M	Hold	60,777	–	–	0.24%	139
2018 Q1	$12.5M	Sell	60,777 -5,798	-9%	-$1.22M	0.24%	152
2017 Q4	$12.6M	Sell	66,575 -24,900	-27%	-$4.77M	0.24%	143
2017 Q3	$17.3M	Sell	91,475 -20,235	-18%	-$3.66M	0.33%	105
2017 Q2	$19.5M	Hold	111,710	–	–	0.39%	83
2017 Q1	$17.2M	Hold	111,710	–	–	0.34%	109
2016 Q4	$15.8M	Hold	111,710	–	–	0.32%	120
2016 Q3	$17.8M	Sell	111,710 -6	-0%	-$925	0.38%	84
2016 Q2	$16.5M	Sell	111,716 -4,800	-4%	-$708K	0.36%	93
2016 Q1	$16.5M	Sell	116,516 -5,860	-5%	-$785K	0.36%	96
2015 Q4	$17.4M	Sell	122,376 -336	-0.3%	-$44.8K	0.38%	84
2015 Q3	$15M	Hold	122,712	–	–	0.34%	91
2015 Q2	$15.9M	Hold	122,712	–	–	0.33%	96
2015 Q1	$16.5M	Hold	122,712	–	–	0.34%	94
2014 Q4	$15.4M	Hold	122,712	–	–	0.32%	101
2014 Q3	$14.9M	Hold	122,712	–	–	0.33%	94
2014 Q2	$14.5M	Sell	122,712 -156,192	-56%	-$18.4M	0.32%	98
2014 Q1	$33.5M	Sell	278,904 -15,236	-5%	-$1.81M	0.76%	32
2013 Q4	$32.8M	Sell	294,140 -42,000	-12%	-$4.18M	0.77%	31
2013 Q3	$31M	Sell	336,140 -42,619	-11%	-$3.85M	0.78%	26
2013 Q2	$32.1M	Buy	+378,759	New	+$31.5M	0.86%	22

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Quadrant's TMO Position: Q4 2021 in Review

First Quadrant sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 17 shares — an estimated $10K sold.

First Quadrant first reported a position in TMO in Q2 2013 and held it in 26 quarters. The position peaked at $33.5M in Q1 2014. 2,343 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

First Quadrant reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
First Quadrant sold 17 Thermo Fisher Scientific shares in Q4 2021, an estimated $10K.
First Quadrant first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 26 quarters.
First Quadrant's Thermo Fisher Scientific position peaked at $33.5M in Q1 2014.
2,343 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on First Quadrant's 13F filing for Q4 2021, filed 27 Jan 2022.